|
|
||||||||
Articles |
Transforming growth factor-beta1 (TGFbeta1) is inhibitory to most epithelia, but its role in the control of proliferation of prostatic epithelium is unclear. In some cells, TGFbeta1 inhibition is achieved by up-regulation of cyclin-dependent kinase (cdk) inhibitors including p15, p21 and p27. Our aims were to determine whether the effects of TGFbeta1 on human prostatic epithelial cell cycle kinetics were mediated by alterations in the levels of the cdk inhibitors p15, p16, p21 and p27 and hypo-phosphorylated retinoblastoma protein (Rb). Human prostatic epithelial cells in primary culture were grown in the presence of TGFbeta1 (0-10 ng/ml) for up to 4 days and proliferation assessed using a [3H]thymidine uptake assay. Levels of p15, p16, p21 and p27 were measured at both mRNA and protein level by means of a reverse transcriptase PCR-based assay and Western analysis. Rb and cdk2 levels were measured. Exogenous TGFbeta1 (0-5 ng/ml) inhibited proliferation. This was associated with blocking of the cell cycle at G1, and up to 4-fold increases in p15, p21 and p27 mRNA levels, but no change was observed in p16 mRNA levels; these changes were not blocked by cycloheximide. Increased levels of p15, p21 and p27 protein were also accompanied by increased levels of hypo-phosphorylated Rb and decreased cdk2 kinase activity. TGFbeta1 has mainly inhibitory effects on benign human prostatic epithelium, which are caused by up-regulation of cdk inhibitors, hypo-phosphorylation of Rb and delaying of the cell cycle in G1.
This article has been cited by other articles:
![]() |
F. Ghannad, D. Nica, M. I. Garcia Fulle, D. Grenier, E. E. Putnins, S. Johnston, A. Eslami, L. Koivisto, G. Jiang, M. D. McKee, et al. Absence of {alpha}v{beta}6 Integrin Is Linked to Initiation and Progression of Periodontal Disease Am. J. Pathol., May 1, 2008; 172(5): 1271 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Fischer, S. Zheng, R. Fan, and J. A. Voynow Neutrophil elastase inhibition of cell cycle progression in airway epithelial cells in vitro is mediated by p27kip1 Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L762 - L768. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Turley, E. C. Finger, N. Hempel, T. How, T. A. Fields, and G. C. Blobe The Type III Transforming Growth Factor-{beta} Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer Cancer Res., February 1, 2007; 67(3): 1090 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boxall, S. T. Holgate, and D. E. Davies The contribution of transforming growth factor-{beta} and epidermal growth factor signalling to airway remodelling in chronic asthma Eur. Respir. J., January 1, 2006; 27(1): 208 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yu, D. A. Quinn, H. G. Garg, and C. A. Hales Cyclin-Dependent Kinase Inhibitor p27Kip1, But Not p21WAF1/Cip1, Is Required for Inhibition of Hypoxia-Induced Pulmonary Hypertension and Remodeling by Heparin in Mice Circ. Res., October 28, 2005; 97(9): 937 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Boyer Arnold and M. Korc Smad7 Abrogates Transforming Growth Factor-{beta}1-mediated Growth Inhibition in COLO-357 Cells through Functional Inactivation of the Retinoblastoma Protein J. Biol. Chem., June 10, 2005; 280(23): 21858 - 21866. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. McCarty Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380. [Abstract] [PDF] |
||||
![]() |
F. Zhang, L. D. Nielsen, J. J. Lucas, and R. J. Mason Transforming Growth Factor-{beta} Antagonizes Alveolar Type II Cell Proliferation Induced by Keratinocyte Growth Factor Am. J. Respir. Cell Mol. Biol., December 1, 2004; 31(6): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Tomlinson, S. H. Freestone, O. C. Grace, and A. A. Thomson Differential Effects of Transforming Growth Factor-{beta}1 on Cellular Proliferation in the Developing Prostate Endocrinology, September 1, 2004; 145(9): 4292 - 4300. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kalinina, A. Agrotis, Y. Antropova, O. Ilyinskaya, V. Smirnov, E. Tararak, and A. Bobik Smad Expression in Human Atherosclerotic Lesions: Evidence for Impaired TGF-{beta}/Smad Signaling in Smooth Muscle Cells of Fibrofatty Lesions Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1391 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cheng and J. P. Grande Transforming Growth Factor-{beta} Signal Transduction and Progressive Renal Disease Experimental Biology and Medicine, December 1, 2002; 227(11): 943 - 956. [Abstract] [Full Text] |
||||
![]() |
M. Tavassoli, J. Soltaninia, J. Rudnicka, D. Mashanyare, N. Johnson, and J. Gaken Tamoxifen inhibits the growth of head and neck cancer cells and sensitizes these cells to cisplatin induced-apoptosis: role of TGF-{beta}1 Carcinogenesis, October 1, 2002; 23(10): 1569 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Grande, G. M. Warner, H. J. Walker, A. N. K. Yusufi, J. Cheng, C. E. Gray, J. B. Kopp, and K. A. Nath TGF-{beta}1 Is an Autocrine Mediator of Renal Tubular Epithelial Cell Growth and Collagen IV Production Experimental Biology and Medicine, March 1, 2002; 227(3): 171 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lapointe and C. Labrie Role of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Androgen-Induced Inhibition of CAMA-1 Breast Cancer Cell Proliferation Endocrinology, October 1, 2001; 142(10): 4331 - 4338. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Chaffin, K. M. Schwinof, and R. L. Stouffer Gonadotropin and Steroid Control of Granulosa Cell Proliferation During the Periovulatory Interval in Rhesus Monkeys Biol Reprod, September 1, 2001; 65(3): 755 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, K. Graziano, T. Pham, C. D. Logsdon, and D. M. Simeone Adenovirus-mediated gene transfer of dominant-negative Smad4 blocks TGF-{beta} signaling in pancreatic acinar cells Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1247 - G1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Don, Y.-H. Chang, K.-K. Chen, L.-K. Ho, and Y.-P. Chau Induction of CDK Inhibitors (p21WAF1 and p27Kip1) and Bak in the {beta}-Lapachone-Induced Apoptosis of Human Prostate Cancer Cells Mol. Pharmacol., April 1, 2001; 59(4): 784 - 794. [Abstract] [Full Text] |
||||
![]() |
S. L. Green, R. A. Freiberg, and A. J. Giaccia p21Cip1 and p27Kip1 Regulate Cell Cycle Reentry after Hypoxic Stress but Are Not Necessary for Hypoxia-Induced Arrest Mol. Cell. Biol., February 15, 2001; 21(4): 1196 - 1206. [Abstract] [Full Text] |
||||
![]() |
H. Ouyang, L.-j. Mou, C. Luk, N. Liu, J. Karaskova, J. Squire, and M.-S. Tsao Immortal Human Pancreatic Duct Epithelial Cell Lines with Near Normal Genotype and Phenotype Am. J. Pathol., November 1, 2000; 157(5): 1623 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Pan, C. J. Hetherington, and D.-E. Zhang CCAAT/Enhancer-binding Protein Activates the CD14 Promoter and Mediates Transforming Growth Factor beta Signaling in Monocyte Development J. Biol. Chem., August 13, 1999; 274(33): 23242 - 23248. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |